ananta medicare
ENDLESS CARE ABOUT YOUR HEALTH
#
Great Britain
News of the company

Ananta medicare took part in all-ukrainian training program «The art of treatment: postgraduate course of professional development»

On December 6, 2018, the All-Ukrainian training program for doctors of the therapeutic profile "The Art of Treatment: A Postgraduate Course in Professional Development" was held in Lutsk. The event was attended by doctors of various specialties: general practitioners, family doctors, gastroenterologists, cardiologists, neurologists and others.

Ananta Medicare participated in the event with its branded stands. At the conference, two reports on original combinations of Lactofor and Memostim were presented.           

Vashchilina Natalia Alexandrovna (Coordinator of the expert group on gastroenterology of Volyn Regional State Administration of Healthcare, Head of the Department of Gastroenterology of Volyn Regional Clinical Hospital) has presented the following report: “Current approaches to the management of patients with irritable bowel syndrome with constipation.”   

The report has shown the topical questions of the clinical picture, diagnosis and management of patients with irritable bowel syndrome with constipation (according to the latest Rome IV criteria). Natalia Alexandrovna has focused on the new original Lactofor combination, which, due to its composition, makes it possible to comprehensively solve the problem of constipation in patients with irritable bowel syndrome.           

Malyarskaya Natalia Vladimirovna, Associate Professor of the Department of Neurology, Lviv National Medical University named after D. Galitsky, has presented a report on a phytonootropic called Memostim, namely “Neuroplasticity and the possibility of correcting cognitive disorders.” During the report, Malyarskaya N.V. emphasized that today the problem of cognitive disorders attracts the attention of doctors of various specialties. In patients with pre-dementia cognitive impairment, early diagnosis of cerebral diseases significantly increases the chances of successful treatment of this problem. Within the report, Malyarskaya N.V. emphasized the positive experience of the use of Memostim® for such category of patients.

This is due to the ability of Memostim to improve systemic microcirculation by means of the presence of Ginkgo Biloba extract, as well as Bacopa Monier extract exhibits a nootropic effect, such as improvement of memory, attention and learning ability, also protection of nerve cells, as well as promotion of growth and development of new nerve cells. The report aroused great interest and a professional discussion among the audience.           

At the end of the conference, all participants received certificates of participation and information materials.